| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $63.3M | +9.7% |
| Cost of Revenue | $20.9M | +0.2% |
| R&D Expense | $11.9M | -79.0% |
| SG&A Expense | $96.4M | +9.9% |
| Operating Income | -$70.2M | +36.4% |
| Interest Expense | $10.1M | -25.3% |
| Pre-tax Income | -$33.5M | +72.2% |
| Income Tax | -$620K | -298.7% |
| Net Income | $6.8M | +114.8% |
| EPS (Basic) | -$0.07 | +97.4% |
| EPS (Diluted) | -$0.07 | +97.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.4M | +38.6% |
| Accounts Receivable | $29.8M | +191.1% |
| Inventory | $9.6M | -33.3% |
| Current Assets | $123.8M | +37.0% |
| Total Assets | $185.5M | +28.7% |
| Current Liabilities | $49.7M | -30.3% |
| Long-term Debt | $52.4M | -9.6% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.8M | +18.0% |
| Investing Cash Flow | $10.1M | +167.5% |
| Financing Cash Flow | $77.4M | +9.6% |
| $123.4M |
| -15.4% |
| Stockholders' Equity | $49.9M | +119.3% |